Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
about
Vinclozolin exposure in utero induces postpubertal prostatitis and reduces sperm production via a reversible hormone-regulated mechanismAndrogen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo.A screen for transcription factor targets of glycogen synthase kinase-3 highlights an inverse correlation of NFκB and androgen receptor signaling in prostate cancerLoss of the androgen receptor cofactor p44/WDR77 induces astrogliosis.Cancer cachexia and anabolic interventions: a case report.Neuronal androgen receptor regulates insulin sensitivity via suppression of hypothalamic NF-κB-mediated PTP1B expression.Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis.Tumor suppressor PAX6 functions as androgen receptor co-repressor to inhibit prostate cancer growthSusceptibility to autoimmunity and B cell resistance to apoptosis in mice lacking androgen receptor in B cells.Integrins in prostate cancer progressionNF-kappaB regulates androgen receptor expression and prostate cancer growth.Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients.Reduced tumor necrosis factor receptor-associated death domain expression is associated with prostate cancer progression.Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation.Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse.Expression and shedding of endothelial protein C receptor in prostate cancer cells.
P2860
Q28581972-0278DC5F-771D-4494-AC43-1893707C5A9AQ33607836-AF041770-2340-4CFD-927F-A323EE9C06B8Q34483490-5115B2C0-8E2E-4471-8F95-805986BA8C12Q36172838-6FD4BFDB-1315-4F1E-AEC1-E17D733ADD89Q36421059-764C1E96-92E2-4164-9F77-4893E44A03FBQ36560660-BB0E1A23-3380-461E-85D9-D2E9E41EEF85Q36904589-D21FD570-1E96-40B4-A9B3-E187BB59740AQ37059542-82D8D7B2-CDE3-47B2-9378-33969163A65CQ37155385-B3820013-ACBC-4BDD-9A62-9EA8EDB2B82CQ37182177-AEF878F2-DDBE-4EF7-A6B3-946A46F59C53Q37278416-1CE0F231-2261-410D-8DB1-AF0E5FBF5606Q37596681-E64BE95A-DE97-4100-ACB8-63E85CF72A04Q39771305-CEDC7855-FE97-4EFC-BBCF-534B8E0BCC76Q39945610-AA44BAB6-9CDF-47E5-A955-D455BE2A2718Q42022163-BFDD5B59-2B17-4C84-8A6F-F2EA734169DEQ42239302-737C4EC1-A655-4A2D-B7CA-E12922DEB1AC
P2860
Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Interruption of nuclear factor ...... e prostate cancer LNCaP cells.
@en
type
label
Interruption of nuclear factor ...... e prostate cancer LNCaP cells.
@en
prefLabel
Interruption of nuclear factor ...... e prostate cancer LNCaP cells.
@en
P2093
P1433
P1476
Interruption of nuclear factor ...... e prostate cancer LNCaP cells.
@en
P2093
Chawnshang Chang
Hong-Yo Kang
Hui-Kuan Lin
Kuang-Hsiang Chuang
LeRoy A Hanchett
Meng-Ying Tsai
Mujib M Rahman
Saleh Altuwaijri
Shuyuan Yeh
P304
P407
P577
2003-11-01T00:00:00Z